FDA Regulation of Prescription Drugs

N Engl J Med. 2017 Feb 16;376(7):674-682. doi: 10.1056/NEJMra1602972.

Authors

Audrey L Gassman¹, Christine P Nguyen¹, Hylton V Joffe¹

Affiliation

¹ From the Division of Bone, Reproductive, and Urologic Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD.

PMID: 28199811
DOI: 10.1056/NEJMra1602972

No abstract available

Publication types

Review

MeSH terms

Drug Approval*
Drug Labeling / legislation & jurisprudence
Drug Labeling / standards
Government Regulation*
Prescription Drugs*
Product Surveillance, Postmarketing*
Risk Assessment
United States
United States Food and Drug Administration

Substances

Prescription Drugs